[go: up one dir, main page]

AU3418389A - Nerve growth factor peptides - Google Patents

Nerve growth factor peptides

Info

Publication number
AU3418389A
AU3418389A AU34183/89A AU3418389A AU3418389A AU 3418389 A AU3418389 A AU 3418389A AU 34183/89 A AU34183/89 A AU 34183/89A AU 3418389 A AU3418389 A AU 3418389A AU 3418389 A AU3418389 A AU 3418389A
Authority
AU
Australia
Prior art keywords
growth factor
nerve growth
factor peptides
peptides
nerve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34183/89A
Inventor
James Charles Kauer
Frank M. Longo
William C. Mobley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of AU3418389A publication Critical patent/AU3418389A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU34183/89A 1988-03-28 1989-03-20 Nerve growth factor peptides Abandoned AU3418389A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17397588A 1988-03-28 1988-03-28
US173975 1988-03-28
US29969889A 1989-01-10 1989-01-10
US299698 1989-01-23

Publications (1)

Publication Number Publication Date
AU3418389A true AU3418389A (en) 1989-10-16

Family

ID=26869739

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34183/89A Abandoned AU3418389A (en) 1988-03-28 1989-03-20 Nerve growth factor peptides

Country Status (4)

Country Link
EP (1) EP0335637A3 (en)
AU (1) AU3418389A (en)
PT (1) PT90138A (en)
WO (1) WO1989009225A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4004573A1 (en) * 1989-02-17 1990-08-23 Tanabe Seiyaku Co NEW TRIAL AND HIS PRODUCTION
SE465573B (en) * 1989-03-14 1991-09-30 Lope Medicine Ab NERVOUS GROWTH FACTOR Peptides, ANTIBODY CORRESPONDING MATERIALS AND PROCEDURES FOR DETERMINING NATIVE NERVOUS GROWTH FACTORS
JP2745351B2 (en) * 1991-02-14 1998-04-28 富士写真フイルム株式会社 Peptide derivatives and their uses
AU3734693A (en) * 1992-03-17 1993-10-21 Board Of Regents, The University Of Texas System Neurotrophic peptides
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases
GB9402331D0 (en) * 1994-02-07 1994-03-30 Univ Mcgill Nerve growth factor structural analogs and their uses
US6291247B1 (en) 1994-05-11 2001-09-18 Queen's University At Kingston Methods of screening for factors that disrupt neurotrophin conformation and reduce neurotrophin biological activity
GB9616105D0 (en) * 1996-07-31 1996-09-11 Univ Kingston TrkA binding site of NGF
IT1306704B1 (en) * 1999-05-26 2001-10-02 Sirs Societa Italiana Per La R MONOCLONAL ANTIBODIES AND ITS SYNTHETIC OR BIOTECHNOLOGICAL DERIVATIVES ENABLE TO ACT AS ANTAGONIST MOLECULES FOR NGF.
ZA200502612B (en) 2002-10-08 2007-07-25 Rinat Neuroscience Corp Methods for treating post-surgical pain by administering a nerve crowth factor antagonist and compositions containing the same
UA80447C2 (en) 2002-10-08 2007-09-25 Methods for treating pain by administering nerve growth factor antagonist and opioid analgesic
AU2003304238A1 (en) 2002-10-08 2005-01-13 Rinat Neuroscience Corp. Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same
US7569364B2 (en) 2002-12-24 2009-08-04 Pfizer Inc. Anti-NGF antibodies and methods using same
SI2263692T1 (en) 2002-12-24 2020-10-30 Rinat Neuroscience Corp. Anti-NGF antibodies and methods using same
US9498530B2 (en) 2002-12-24 2016-11-22 Rinat Neuroscience Corp. Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
KR20050111598A (en) 2003-02-19 2005-11-25 리나트 뉴로사이언스 코퍼레이션 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same
US7576206B2 (en) 2003-08-14 2009-08-18 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US7223745B2 (en) 2003-08-14 2007-05-29 Cephalon, Inc. Proteasome inhibitors and methods of using the same
DK2206728T3 (en) 2004-04-07 2018-04-23 Rinat Neuroscience Corp METHODS OF TREATING BONE CANCER PAIN BY SUBMITTING A NERVOUS FACTOR-ANTAGONISTIC ANTIBODY
AU2005252297A1 (en) * 2004-06-10 2005-12-22 Enkam Pharmaceuticals A/S Heparin binding peptide
US7468383B2 (en) 2005-02-11 2008-12-23 Cephalon, Inc. Proteasome inhibitors and methods of using the same
RU2410392C2 (en) * 2009-02-16 2011-01-27 Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии имени В.В. Закусова РАМН Dipeptide mimetics of ngf and bdnf neurotrophins
AU2010341530B2 (en) 2009-12-22 2016-03-10 Cephalon, Inc. Proteasome inhibitors and processes for their preparation, purification and use
PT3333188T (en) 2010-08-19 2022-03-28 Zoetis Belgium S A Anti-ngf antibodies and their use
US9617334B2 (en) 2012-06-06 2017-04-11 Zoetis Services Llc Caninized anti-NGF antibodies and methods thereof
CA3093772C (en) 2018-03-12 2024-04-16 Zoetis Services Llc Anti-ngf antibodies and methods thereof
CN113845583B (en) * 2020-06-28 2023-08-11 江苏中新医药有限公司 Modified recombinant human nerve growth factor and preparation method thereof
US20230348608A1 (en) 2022-04-27 2023-11-02 Regeneron Pharmaceuticals, Inc. Treatment Of Arthropathy Based Upon Stratification Of Osteoarthritis Polygenic Risk Score
US20240310383A1 (en) 2023-03-17 2024-09-19 Regeneron Pharmaceuticals, Inc. Proteomic Risk Score For Osteoarthritis (OA)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230691A (en) * 1978-05-23 1980-10-28 The Massachusetts General Hospital Nerve growth factor antibody and process
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
WO1986004334A1 (en) * 1985-01-18 1986-07-31 MERCK Patent Gesellschaft mit beschränkter Haftung Immunoregulatory peptides

Also Published As

Publication number Publication date
WO1989009225A1 (en) 1989-10-05
EP0335637A2 (en) 1989-10-04
PT90138A (en) 1989-11-10
EP0335637A3 (en) 1991-03-13

Similar Documents

Publication Publication Date Title
AU3418389A (en) Nerve growth factor peptides
AU591848B1 (en) Electrotherapy arrangement
AU3151689A (en) Improved cryo-slammer
AU3715993A (en) N-isopropylheteroaryloxyacetanilides
AU3228789A (en) Biologically active proteins
AU3362889A (en) Peptide derivatives
AU588072B2 (en) Human preproinsulin-like growth factor i
AU3163389A (en) 5-amino-1-phenylpyrazoles
AU3588189A (en) Polypeptide compounds
AU3414689A (en) Therapeutic peptides
AU2864489A (en) 16-dehydro-vitamin d3-derivatives
AU3642589A (en) 1-aryl-2-naphthoylamines
AU3977589A (en) Novel peptides
AU4385689A (en) Electrode
AU3334389A (en) Rutheniumcomplex-compounds
AU3234289A (en) Co-dispenser
AU610900B2 (en) Immunosuppressant peptides
AU3159784A (en) Insuliin-Potentiating peptides from human growth hormome
AU3013389A (en) Human nerve growth factor gene segment
AU4577589A (en) Mowers
AU3804589A (en) Novel proteins
AU1967288A (en) Growth hormone related peptide
AU3300089A (en) Triazoloazines
AU3315089A (en) 2-substituted-2-cyclopentenones
AU3804689A (en) Modified proteins